Skip to main content
Erschienen in: Head and Neck Pathology 3/2016

19.11.2015 | Case Report

NUT Carcinoma of the Sublingual Gland

verfasst von: S. Andreasen, C. A. French, M. Josiassen, C. H. Hahn, K. Kiss

Erschienen in: Head and Neck Pathology | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

NUT carcinoma (NC) is a recently described, rare and extremely aggressive cancer primarily located to supradiaphragmatic structures and affecting young individuals. NC is characterized by translocations involving the NUT gene on 15q14 with the most common translocation partner gene being BRD4 on 19p13, resulting in the t(15;19)(q14;p13) karyotype. NC is poorly differentiated and is likely to be overlooked and misdiagnosed as poorly differentiated squamous cell carcinoma (SCC) when immunohistochemical evaluation of NUT protein expression is omitted. Previously, NC has been found in the parotid and submandibular glands and we present the first case in the sublingual gland arising in a 40-year-old woman. We discuss the diagnostic considerations for poorly differentiated carcinomas of the salivary glands and advocate the inclusion of NUT immunohistochemistry in this setting. Not only does the NC diagnosis confer a grave prognosis when treated as SCC as illustrated by the present case, but is important for the inclusion of patients in ongoing clinical trials.
Literatur
1.
Zurück zum Zitat French CA. Pathogenesis of NUT midline carcinoma. Annu Rev Pathol Mech Dis. 2012;7:247–65.CrossRef French CA. Pathogenesis of NUT midline carcinoma. Annu Rev Pathol Mech Dis. 2012;7:247–65.CrossRef
2.
Zurück zum Zitat French CA, Miyoshi I, Kubonishi I, et al. BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma. Cancer Res. 2003;63:304–7.PubMed French CA, Miyoshi I, Kubonishi I, et al. BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma. Cancer Res. 2003;63:304–7.PubMed
3.
Zurück zum Zitat French CA, Ramirez CL, Kolmakova J, et al. BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells. Oncogene. 2008;27:2237–42.CrossRefPubMed French CA, Ramirez CL, Kolmakova J, et al. BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells. Oncogene. 2008;27:2237–42.CrossRefPubMed
4.
Zurück zum Zitat French CA, den Bakker M. NUT carcinoma. In: Travis W, Brambilla E, Müller-Hermelink H, Harris C, editors. World health organization classification of tumours of lung, pleura, thymus and heart. 4th ed. Lyon: IARC Press; 2015. p. 229–31. French CA, den Bakker M. NUT carcinoma. In: Travis W, Brambilla E, Müller-Hermelink H, Harris C, editors. World health organization classification of tumours of lung, pleura, thymus and heart. 4th ed. Lyon: IARC Press; 2015. p. 229–31.
5.
Zurück zum Zitat French CA, Kutok JL, Faquin WC, et al. Midline carcinoma of children and young adults with NUT rearrangement. J Clin Oncol. 2004;22:4135–9.CrossRefPubMed French CA, Kutok JL, Faquin WC, et al. Midline carcinoma of children and young adults with NUT rearrangement. J Clin Oncol. 2004;22:4135–9.CrossRefPubMed
6.
Zurück zum Zitat Bauer DE, Mitchell CM, Strait KM, et al. Clinicopathologic features and long-term outcomes of NUT midline carcinoma. Clin Cancer Res. 2012;18:5773–9.CrossRefPubMedPubMedCentral Bauer DE, Mitchell CM, Strait KM, et al. Clinicopathologic features and long-term outcomes of NUT midline carcinoma. Clin Cancer Res. 2012;18:5773–9.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Stelow EB, Bellizzi AM, Taneja K, et al. NUT rearrangement in undifferentiated carcinomas of the upper aerodigestive tract. Am J Surg Pathol. 2008;32:828–34.CrossRefPubMed Stelow EB, Bellizzi AM, Taneja K, et al. NUT rearrangement in undifferentiated carcinomas of the upper aerodigestive tract. Am J Surg Pathol. 2008;32:828–34.CrossRefPubMed
9.
Zurück zum Zitat Ziai J, French CA, Zambrano E. NUT gene rearrangement in a poorly-differentiated carcinoma of the submandibular gland. Head Neck Pathol. 2010;4:163–8.CrossRefPubMedPubMedCentral Ziai J, French CA, Zambrano E. NUT gene rearrangement in a poorly-differentiated carcinoma of the submandibular gland. Head Neck Pathol. 2010;4:163–8.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat den Bakker MA, Beverloo BH, van den Heuvel-Eibrink MM, et al. NUT midline carcinoma of the parotid gland with mesenchymal differentiation. Am J Surg Pathol. 2009;33:1253–8.CrossRef den Bakker MA, Beverloo BH, van den Heuvel-Eibrink MM, et al. NUT midline carcinoma of the parotid gland with mesenchymal differentiation. Am J Surg Pathol. 2009;33:1253–8.CrossRef
11.
Zurück zum Zitat Edge SB, Byrd DR, Compton CC, et al., editors. AJCC cancer staging manual. 7th ed. New York: Springer; 2010. p. 79–86. Edge SB, Byrd DR, Compton CC, et al., editors. AJCC cancer staging manual. 7th ed. New York: Springer; 2010. p. 79–86.
12.
Zurück zum Zitat French CA, Rahman S, Walsh EM, et al. NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism. Cancer Discov. 2014;4:928–41.CrossRefPubMedPubMedCentral French CA, Rahman S, Walsh EM, et al. NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism. Cancer Discov. 2014;4:928–41.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Tsang WYW, Kuo TT, Chan JKC. Lymphoepithelial carcinoma. In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. World Health organization classification of tumours pathology & genetics head and neck tumours. Lyon: IARC press; 2005. p. 251–2. Tsang WYW, Kuo TT, Chan JKC. Lymphoepithelial carcinoma. In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. World Health organization classification of tumours pathology & genetics head and neck tumours. Lyon: IARC press; 2005. p. 251–2.
14.
Zurück zum Zitat Nagao T, Sugano I, Ishida Y, et al. Primary large-cell neuroendocrine carcinoma of the parotid gland: immunohistochemical and molecular analysis of two cases. Mod Pathol. 2000;13:554–61.CrossRefPubMed Nagao T, Sugano I, Ishida Y, et al. Primary large-cell neuroendocrine carcinoma of the parotid gland: immunohistochemical and molecular analysis of two cases. Mod Pathol. 2000;13:554–61.CrossRefPubMed
15.
Zurück zum Zitat Haack H, Johnson LA, Fry CJ, et al. Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody. Am J Surg Pathol. 2009;33:984–91.CrossRefPubMedPubMedCentral Haack H, Johnson LA, Fry CJ, et al. Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody. Am J Surg Pathol. 2009;33:984–91.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Fang W, French CA, Cameron MJ, et al. Clinicopathological significance of NUT rearrangements in poorly differentiated malignant tumors of the upper respiratory tract. Int J Surg Pathol. 2012;21:102–10.CrossRefPubMed Fang W, French CA, Cameron MJ, et al. Clinicopathological significance of NUT rearrangements in poorly differentiated malignant tumors of the upper respiratory tract. Int J Surg Pathol. 2012;21:102–10.CrossRefPubMed
17.
Zurück zum Zitat Stenman G, Persson F, Andersson MK. Diagnostic and therapeutic implications of new molecular biomarkers in salivary gland cancers. Oral Oncol. 2014;50:683–90.CrossRefPubMed Stenman G, Persson F, Andersson MK. Diagnostic and therapeutic implications of new molecular biomarkers in salivary gland cancers. Oral Oncol. 2014;50:683–90.CrossRefPubMed
Metadaten
Titel
NUT Carcinoma of the Sublingual Gland
verfasst von
S. Andreasen
C. A. French
M. Josiassen
C. H. Hahn
K. Kiss
Publikationsdatum
19.11.2015
Verlag
Springer US
Erschienen in
Head and Neck Pathology / Ausgabe 3/2016
Elektronische ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-015-0672-7

Weitere Artikel der Ausgabe 3/2016

Head and Neck Pathology 3/2016 Zur Ausgabe

Sine qua non Radiology-Pathology

Dedifferentiated Chondrosarcoma of the Larynx

Sine qua non Clinicopathologic Correlat

Extensive Melanotic Neuroectodermal Tumor of Infancy

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …